73 related articles for article (PubMed ID: 21355953)
1. Downregulation of the B-cell receptor signaling component CD79b in plasma cell myeloma: a possible post transcriptional regulation.
Huang X; Takata K; Sato Y; Tanaka T; Ichimura K; Tamura M; Oka T; Yoshino T
Pathol Int; 2011 Mar; 61(3):122-9. PubMed ID: 21355953
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterisation of the CD79a and CD79b subunits of the B cell receptor complex in the gray short-tailed opossum (Monodelphis domestica) and tammar wallaby (Macropus eugenii): Delayed B cell immunocompetence in marsupial neonates.
Duncan L; Webster K; Gupta V; Nair S; Deane E
Vet Immunol Immunopathol; 2010 Aug; 136(3-4):235-47. PubMed ID: 20399507
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukaemia.
Astsaturov IA; Matutes E; Morilla R; Seon BK; Mason DY; Farahat N; Catovsky D
Leukemia; 1996 May; 10(5):769-73. PubMed ID: 8656670
[TBL] [Abstract][Full Text] [Related]
4. Asymmetrical phosphorylation and function of immunoreceptor tyrosine-based activation motif tyrosines in B cell antigen receptor signal transduction.
Pao LI; Famiglietti SJ; Cambier JC
J Immunol; 1998 Apr; 160(7):3305-14. PubMed ID: 9531288
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line.
Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A
Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858
[TBL] [Abstract][Full Text] [Related]
6. Role of the extracellular and transmembrane domain of Ig-alpha/beta in assembly of the B cell antigen receptor (BCR).
Dylke J; Lopes J; Dang-Lawson M; Machtaler S; Matsuuchi L
Immunol Lett; 2007 Sep; 112(1):47-57. PubMed ID: 17675166
[TBL] [Abstract][Full Text] [Related]
7. Frequent downregulation or loss of CD79a expression in plasma cell myelomas: potential clue for diagnosis.
Tanaka T; Ichimura K; Sato Y; Takata K; Morito T; Tamura M; Kondo E; Ohara N; Yanai H; Sakai M; Takahashi S; Yoshino T
Pathol Int; 2009 Nov; 59(11):804-8. PubMed ID: 19883431
[TBL] [Abstract][Full Text] [Related]
8. Discordant expression of immunoglobulin and its associated molecule mb-1/CD79a is frequently found in mediastinal large B cell lymphomas.
Kanavaros P; Gaulard P; Charlotte F; Martin N; Ducos C; Lebezu M; Mason DY
Am J Pathol; 1995 Mar; 146(3):735-41. PubMed ID: 7887454
[TBL] [Abstract][Full Text] [Related]
9. Plasma cell differentiation and multiple myeloma.
Shapiro-Shelef M; Calame K
Curr Opin Immunol; 2004 Apr; 16(2):226-34. PubMed ID: 15023417
[TBL] [Abstract][Full Text] [Related]
10. CD74 is expressed by multiple myeloma and is a promising target for therapy.
Burton JD; Ely S; Reddy PK; Stein R; Gold DV; Cardillo TM; Goldenberg DM
Clin Cancer Res; 2004 Oct; 10(19):6606-11. PubMed ID: 15475450
[TBL] [Abstract][Full Text] [Related]
11. Isoforms of the CD79 signal transduction component of the macropod B-cell receptor.
Suthers AN; Young LJ
Dev Comp Immunol; 2014 Dec; 47(2):185-90. PubMed ID: 25064685
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
Kapoor GS; Kapitonov D; O'Rourke DM
Cancer Res; 2004 Sep; 64(18):6444-52. PubMed ID: 15374953
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
Cabezudo E; Carrara P; Morilla R; Matutes E
Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
[TBL] [Abstract][Full Text] [Related]
14. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
15. Expression and function of toll-like receptors in multiple myeloma patients: toll-like receptor ligands promote multiple myeloma cell growth and survival via activation of nuclear factor-kappaB.
Xu Y; Zhao Y; Huang H; Chen G; Wu X; Wang Y; Chang W; Zhu Z; Feng Y; Wu D
Br J Haematol; 2010 Sep; 150(5):543-53. PubMed ID: 20629663
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.
Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M
J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980
[TBL] [Abstract][Full Text] [Related]
17. POU2AF1, an amplification target at 11q23, promotes growth of multiple myeloma cells by directly regulating expression of a B-cell maturation factor, TNFRSF17.
Zhao C; Inoue J; Imoto I; Otsuki T; Iida S; Ueda R; Inazawa J
Oncogene; 2008 Jan; 27(1):63-75. PubMed ID: 17621271
[TBL] [Abstract][Full Text] [Related]
18. PKC eta directs induction of IRF-4 expression and Ig kappa gene rearrangement in pre-BCR signaling pathway.
Oda A; Ono T; Yamamoto M; Goitsuka R; Kitamura D
Int Immunol; 2008 Nov; 20(11):1417-26. PubMed ID: 18780722
[TBL] [Abstract][Full Text] [Related]
19. The prevalence and clinical implications of c-kit expression in plasma cell myeloma.
Pruneri G; Ponzoni M; Ferreri AJ; Freschi M; Tresoldi M; Baldini L; Mattioli M; Agnelli L; Govi S; Mancuso P; Agazzi A; Bertolini F; Peccatori J; Bosari S; Gianelli U; Viale G; Neri A
Histopathology; 2006 Apr; 48(5):529-35. PubMed ID: 16623778
[TBL] [Abstract][Full Text] [Related]
20. Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity.
Montero JC; López-Pérez R; San Miguel JF; Pandiella A
Haematologica; 2008 Jun; 93(6):851-9. PubMed ID: 18443272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
